🇺🇸 FDA
Company

Sagimet

Sagimet Biosciences

SGMT pharma USA

Quick answer

Sagimet is a pharma company (SGMT) headquartered in SAN MATEO, CA, USA with 12 tracked pipeline programs.

Pipeline (12)

project

Denifanstat

MASH

Phase 3 · small_molecule · terminated

1 trials project

denifanstat

MASLD

Phase 3 · small_molecule · terminated

1 trials project

3-V Bioscience-2640

Metabolic Syndrome

Phase 2 · small_molecule · completed

1 trials project

TVB-2640

KRAS Gene Mutation

Phase 2 · small_molecule · active

1 trials project

TVB-2640

Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease

Phase 2 · small_molecule · completed

1 trials project

TVB-2640 25 mg (US)

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

Phase 2 · small_molecule · completed

1 trials project

Denifanstat

Healthy

Phase 1 · small_molecule · completed

1 trials project

TVB-2640

Prostatic Neoplasms, Castration-Resistant

Phase 1 · small_molecule · active

1 trials project

TVB-2640

Solid Malignant Tumor

Phase 1 · small_molecule · completed

1 trials project

TVB-2640 - 50 mg

Non-alcoholic Steatohepatitis

Phase 1 · small_molecule · completed

1 trials project

TVB-3567

Acne

Phase 1 · small_molecule · active

1 trials project

[14C]-TVB-2640

Healthy Volunteers

Phase 1 · small_molecule · completed

1 trials

Patents (1)

patent

US 11622968

Heterocyclic modulators of lipid synthesis

Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)